quick_wit. I do not envisage any significant year-end tax

New Post Public Reply Private Reply Replies (1) Message Board
AJH92 quick_wit #2796
404
quick_wit. I do not envisage any significant year-end tax sell-off now. I think people who might have been minded to do that would have done so sooner - either by putting it on the .0001 ask when it appeared briefly a few weeks ago or when there was 100M or less on the bid at .0001 subsequently. Now they have seen how the .0001s got bought out pretty quickly and - over the last few days - how many people have already started buying .0002s on the ask whilst they are still available.

Those that specialize in the bottom end of the OTC market like I do see asks of 200M > 300M disappear in minutes on one stock or another every few days. Most of those do not have the relatively thin share structure of INCC or the real products already on the market or the obvious likelihood of continuous PRs throughout 2018 updating existing lines of development and no doubt some new ones as well.

I agree on your estimate of INCC getting to .0012 at least once relatively early in 2018. I also envisage several runs throughout the year - just like we had in 2017.

From Tuesday January 2, 2018 I think we will see more people buying .0002s in increasing quantities once they realize that even those at the front of the .0001 bid lines aren't going to get filled. We might also get some 1-tick flippers cancel their sell orders at .0002 as it is self-evidently going to run at some point.

Long-term followers have been through this before when the 1/2-tick flippers were gone within a few ticks and the ask thinned right down to 50M/20M/10M in the .0004 > .0010 range and was then much thinner above that.

Most of the several .0005 > .0009/10/11 runs we had in 2017 happened in minutes. The run that started in 2016 Q3 to .0033 took a few days but also allowed trading in .0011 > .0019 range for many weeks.

The 2017 Q4 results will be the first full quarter with revenues from a number of CBD products and I would not be surprised to see more orders for grow houses as the dealer network expands. Also, there is already a realty company looking for suitable properties in the real estate funding of mj businesses project and there is a digital marketing company already signed up.

All in all, there is way more going on in 2018 in terms of catalysts for updates than we had for the any of the previous runs in Q3 2014, Q3 2016 or the several repeat runs in 2017. Those that have built up their inventory of shares across the bottom few price levels can just sit back and relax and trade at leisure on all the surges whenever they occur in 2018. Those of us that were thinking ahead secured a significant proportion of the .0002s on the way down specifically to deny them to 1-tick flippers and make the .0003s thinner on the way up.

Those that follow my method of trading (described in detail numerous times on the DIGX board) have done very well in 2017 and should do so again in 2018.

Tersis Technologies, Inc. (TERS) Stock Research Links

TERS Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

SACHEU Partners with AI to Harness Real Customer Insights

Updated Category News Views 4

Rethinking Beauty Industry's AI Obsession Here’s a breath of fresh air from the otherwise AI-obsessed beauty landscape: SACHEU, the brand that's been turning heads in cosmetics, decided to pair up with Limitless Labs. This partnership isn't about ceding control to machines but amplifying genuine human voices in their product development process. Yeah, it's a...

Continue Reading
Epiclay: Game Changer for Sculptors Debuts

Updated Category News Views 11

Epiclay™ Brings New Energy to Sculpting World Folks, if ever there was a time to break the mold, it’s now, and Ace of Clay’s got us covered with Epiclay™—a fresh take on polymer clay that’s turning heads in the sculpture circuit. Over four long years, Ace of Clay, a brand that's gathered a rather colorful following through captivating sculptures and detailed...

Continue Reading
FSC Revives Frank Lloyd Wright's Planetarium Magic

Updated Category News Views 5

The cosmos are back on the show menu at Florida Southern College, folks. Let's dig into what that means for history buffs and star gazers alike. We're talking about the big reopening of the college's Frank Lloyd Wright designed Planetarium—a space that's been gathering dust for far too long. Dive in with me to see why this is more than just a coat of paint on an old...

Continue Reading
Flux Expands AI Platform to Prove Engineering ROI

Updated Category News Views 7

Navigating the AI Maze: Flux's New Pathways Ever feel like these engineering platforms speak a language of their own? Flux's latest expansion finally offers a translator that matters. It's all about decoding whether your AI investment is delivering the goods. Engineering leaders now have more than just fluffy metrics; Flux breaks down real code-based evidence to show if...

Continue Reading
Mattamy Homes Earns Spot as Top Workplace in Jacksonville

Updated Category News Views 8

Jacksonville's Housing Scene Gets a Boost In a world where everyone seems bent on working down to the bone to climb some imaginary corporate ladder, here comes Jacksonville's own Mattamy Homes with a news flash—it's possible to work, live, and still smile at the end of the day. Recently, they earned themselves a coveted spot among the best workplaces in Jacksonville for...

Continue Reading
Greasezilla Expands Infrastructure with Ashland Facility

Updated Category News Views 35

Greasezilla is shaking up the world of waste management, folks. With municipal sewer systems clogged by fats, oils, and grease, Greasezilla's no-nonsense approach is a breath of fresh air. They've just fired up their new regional hub in Ashland, Virginia, taking another hefty step towards easing this burden on municipalities. This ain't small potatoes—this national...

Continue Reading
EZ Elephant's Ladder-Free Gutter Fix Debuts at Expo

Updated Category News Views 4

A New Leaf in Gutter Maintenance From the ground up, EZ Elephant is redefining how we tackle gutter maintenance. Picture it: never having to teeter on that wobbly ladder again just to unclog your gutters. This American-made solution, showcased at the Western Roofing Expo from September 27–29, 2026, is a game changer. Check out Booth #834 to see this marvel of innovation...

Continue Reading
Oracle Harnesses AI to Streamline Healthcare Payments

Updated Category News Views 8

Oracle Steps into Healthcare's Payment Arena You ever try solving a puzzle with half the pieces missing? Well, that's exactly what healthcare orgs have been doing with their revenue cycles. Oracle (NYSE:ORCL) thinks it’s got the missing pieces. They've announced some slick AI capabilities to grease the wheels of healthcare revenue management. But hey, I've seen grand...

Continue Reading
Apex Dental's Growth Shines in Inc. 5000 Ranking

Updated Category News Views 5

Another Year, Another Milestone for Apex Dental Let's talk about steady growth. Apex Dental Partners has made it onto the Inc. 5000 list for the eighth straight year, landing at No. 3,850. Quite a feat, considering this list only features America's fastest-growing private companies. Apex isn't just maintaining its position out of sheer luck. Revenue shot up by 67% over...

Continue Reading
Key Insights for Launching a Mobile Grooming Biz

Updated Category News Views 4

Riding the Mobile Revolution with Grooming Anyone who's dabbled in grooming knows that moving to a mobile setup isn’t just about freedom and flexibility—it's a whole new ballgame. We're talking Chris Hanvey-level insights here, direct from Easley, S.C. This ain't your average jump in a van and snip some fur operation. Choosing the Right Rig First on the list: the...

Continue Reading

Top 5 Most Recently Viewed Articles

Join the Class Action for Novo Nordisk Investors Today

Updated Category News Views 95

Novo Nordisk A/S Securities Class Action Opportunity Investors who purchased securities of Novo Nordisk A/S (NYSE: NVO) between specific dates have a significant opportunity to engage in a class action lawsuit. This lawsuit is rooted in claims pertaining to misrepresentation of crucial details surrounding the company's clinical trial outcomes and announcements made by the...

Continue Reading
Understanding the Potential Fed Rate Cut: NFP Insights

Updated Category News Views 116

The Implications of the NFP Report on Fed Decisions This month’s jobs report is critical, particularly due to anticipated benchmark revisions to past employment figures. These revisions may indicate more than a million jobs could be adjusted, leading to discussions about a potential rate cut by the Federal Reserve. Key Expectations for the NFP Report Analysts forecast...

Continue Reading
Explore Vegamour's Innovation in Hair Growth Supplements Today

Updated Category News Views 352

Vegamour Unveils GRO+ Advanced Hair Growth Supplements Vegamour, a leader in plant-powered biotech dedicated to enhancing hair longevity, has recently announced a groundbreaking product: the GRO+ Advanced Hair Growth & Density Supplements. This new dual-pill system is designed to combat hair thinning through a unique internal approach that prioritizes health and wellness....

Continue Reading
Coalfire Launches ISO 42001 Certification for Responsible AI Management

Updated Category News Views 384

Coalfire Pioneers ISO 42001 Certification for AI Governance Coalfire is leading the cybersecurity industry by becoming one of the first organizations accredited by the ANSI National Accreditation Board (ANAB) for the ISO/IEC 42001:2023 standard, dedicated to Artificial Intelligence governance. The Need for AI Governance As AI technologies continue to advance rapidly, the...

Continue Reading
Akeso's Ivonescimab Sets New Standards in NSCLC Treatment

Updated Category News Views 143

Akeso's Groundbreaking Clinical Trial Results Akeso, Inc. (9926.HK) is thrilled to share significant breakthroughs from its Phase III clinical study of ivonescimab, a cutting-edge PD-1/VEGF bispecific antibody designed to treat non-small cell lung cancer (NSCLC). The study, known as HARMONi-2/AK112-303, has garnered attention following its publication in The Lancet, one...

Continue Reading